HPE stock drops following disappointing outlook

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Wallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.

Hewlett Packard Enterprise Co. HPE, -2.28% shares fell in the extended session Thursday after the company’s forecast for this year and the next fell short of expectations. HPE shares dropped 4% after hours, following a 2.3% decline to close the regular session at $16.30.

For the current fiscal year, HPE forecasts revenue to grow 4% to 6%, and adjusted earnings of $2.11 to $2.15 a share. Analysts surveyed by FactSet had forecast $2.14 a share on revenue of $29.15 billion. For fiscal 2024, HPE expects revenue growth of 2% to 4%, and adjusted earnings of $1.82 to $2.02 a share. Analysts had forecast fiscal 2024 earnings of $2.15 a share on revenue of $29.62 billion.

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Intuitive Surgical’s stock drops as revenue misses Street viewWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »

CVS voluntarily pulling decongestants from shelves that contain ineffective ingredientWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »

Nvidia says China AI chip ban could result in delays, transition of operationsWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »

Zions Bancorp stock drops as net interest income falls short of expectationsWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »

Rite Aid is closing these 154 stores as part of its bankruptcyBill Peters is a Los Angeles-based MarketWatch reporter who covers earnings.
Source: MarketWatch - 🏆 3. / 97 Read more »

Las Vegas Sands shares rise after $2 billion stock repurchaseJames Rogers is a Financial Columnist for MarketWatch.
Source: MarketWatch - 🏆 3. / 97 Read more »